Case presentation of PSMA-PET imaging of prostate cancer: combination with 18FDG-PET and prostate MRI
Number:28ESURABS0059
Type:Educational Electronic Presentation
Authors: Young Taik Oh
Keywords:prostate cancer, mpMRI, PSMA-PET, FDG-PET
SECTIONS
Educational objective
  1. To understand the essential characteristics of PSMA-PET
  2. To understand the basic interpretation of PSMA-PET
  3. To understand the difference of PSMA-PET between FDG-PET and prostate MRI
  4. To present the typical educational cases of PSMA-PET combined with FDG-PET and prostate MRI in patients with prostate cancer.
Topic Review

The contents will be presented with a image files.

 
 
Conclusions

Prostate cancer is one of the most common cancers in men. PSMA-PET is a new imaging technique for prostate cancer that locates cancer lesions. PSMA-PET uses a PET-sensitive drug (68Ga-PSMA-11) that is US FDA approved. 68Ga-PSMA-11 is a radioactive imaging agent that binds to prostate cancer cells to help localize prostate cancer cells. With this presentation, radiologists can be familiar with PSMA-PET imaging, and this will help them in the daily practice of prostate cancer